Time is brain: Acute stroke management

Australian Family Physician

Volumn 36, Issue 11, 2007, Pages 892-895

  Dhamija, Rajinder K ^a   Donnan, Geoffrey A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; EMERGENCY HEALTH SERVICE; HOSPITAL DEPARTMENT; HUMAN; METHODOLOGY; NURSING; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PATIENT CARE; RADIOGRAPHY; STANDARD; STROKE; TIME;

AUSTRALIA; EFFICIENCY, ORGANIZATIONAL; EMERGENCY MEDICAL SERVICES; HOSPITAL DEPARTMENTS; HUMANS; PATIENT CARE MANAGEMENT; STROKE; TIME FACTORS;

EID: 38449088029     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Thrift AG, Dewey HM, MacDonnell RAL, et al. Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2000;31:2087-92.
2. Murray C, Lopez A. Global mortality, disability, and the distribution of risk factors: global burden of disease study. Lancet 1997;349:1436-42.
3. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000;55:1649-55.
4. Roebers S, Wagner M, Ritter MA, Dornbach F, Wahle K, Heuschmann PU. Attitudes and current practice of primary care physicians in acute stroke management. Stroke 2007;38:1298-303.
5. Morganstem LB, Bartholomew LK, Grotta JC, Staub L, King M, Chan W. Sustained benefit of community and professional interventions to increase acute stroke therapy. Arch Intern Med 2003;163:2198-202.
6. Smith M, Doliszny K, Shahar E, et al. Delayed hospital arrival for acute ischaemic stroke: the Minnesota Stroke Survey. Ann Intern Med 1998;129:190-6.
7. Lacy C, Suh D, Bueno M, Kostis J. Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (STROKE). Stroke 2001;32:63-9.
8. Ma H, Ly J, Donnan G. TIA and stroke: a management guide for GPs. Medicine Today 2007;7:26-33.
9. Agyeman O, Nedeltchev K, Arnold M, et al. Time to admission in acute ischemic stroke and transient ischemic attack. Stroke 2006;37:963-6.
10. Schramm P, Schellinger PD, Fiebach JB, et al. Comparison of CT and CT angiographic source images with diffusion weighted images in patients with acute stroke within 6 hours after onset. Stroke 2002;33:2426-32.
11. Wintermark M, Meuli R, Browaeys, et al. Comparison of CT perfusion and angiography and MRI in selecting stroke patients with acute treatment. Neurology 2007;68:694-7.
12. Tan J, Dillon WP, Liu S, et al. Systematic comparison of perfusion CT and CT angiography in acute stroke patients. Ann Neurol 2007;61:533-43.
13. Parsons MW, Pepper EM Chan V, et al. Perfusion computed topography: prediction of final infarct extent and stroke outcome. Ann Neurol 2005;58:672-9.
14. CAST (Chinese Acute Stroke Trial) Collaborative group. CAST: randomised placebo controlled trial of early aspirin use in 20000 patients with acute stroke. Lancet 1997;349:1641-9.
15. International Stroke Trial Collaborative Group. The International Stroke Trial(IST): a randomised trial of aspirin, subcutaneous heparin, both or neither among 19435 patients with acute ischemic stroke. Lancet 1997;349:1569-81.
16. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischaemic stroke: Houston experience 1996 to 2000. Arch Neurol 2001;58:2009-13.
17. Kaste M, Hacke W, Fieschi C, et al. Results of European Cooperative Acute Stroke Study (ECASS). Cerebrovasc Dis 1995;5:225.
18. Hacke W, Kaste M, Fieschi C, et al. Second European Australasian Cooperative Acute Stroke Study Investigators. Randomised double blind placebo controlled trial of thrombolytic therapy with intravenous ateplase in acute ischemic stroke (ECASSII). Lancet 1998;352:1245-51.
19. Hacke W, Donnan G, Fieschi C, et al. ATLANTIS Trial Investigators, ECASS Trial Investigators, NINDS rt-PA Study Group Investigators, Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rp-PA stroke trials. Lancet 2004;363:768-74.
20. Levi CR, Australasian Stroke Unit Network, New South Wales Greater Metropolitan Transition Taskforce Stroke Initiative, Towards A Safer Culture Stroke Expert Working Group. Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus. Med J Aust 2004;180:634-6.
21. DelZappo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomised trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;1:4-11.
22. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet 1993;342:395-8.
23. Dhamija RK. Comprehensive management of stroke: 'the concept of stroke units'. J Assoc Physicians India 1997;45:902-3.
24. Gilligan AK, Thrift AG, Sturm JW, Dewey HM, MacDonell RAL, Donnan GA. Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit. Cerebrovasc Dis 2005;20:239-44.
25. Cadilhac DA, Lalor EE, Pearce DC, Levi CR, Donnan GA. Access to stroke care units in Australian public hospitals: facts and temporal progress: Intern Med J 2006;36:700-4.
26. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007;6:215-22.
27. Hofmeijer J, Amelink GJ, Algra A, et al. Hemicraniectomy After Middle Cerebral Artery Infarction with Life Threatening Edema Trial (HAMLET). Protocol for a randomised controlled trial of decompressive surgery in space occupying hemispheric infarction. Trials 2006;7:29.
28. Donnan GA, Davis SM, Levi CR. Strategies to improve outcomes after stroke. Med J Aust 2003;178:309-10.